Skyscape Web Viewer : The Maudsley Prescribing Guidelines in Psychiatry : Main Index

View All
Iatrogenic dependence, benzodiazepines/z-drugs/gabapentinoids Benzodiazepine misuse Benzodiazepines, z-drugs and gabapentinoids: dependence, withdrawal effects and discontinuation
Illicit drugs drug-induced excited state drugs of misuse summary interactions with prescribed psychotropic drugs
Iloperidone Antidepressant-induced arrhythmia Antipsychotics - minimum effective doses Equivalent doses Quick reference for licensed maximum doses Relative adverse effects - a rough guide
immediate-release (IR) preparations attention deficit hyperactivity disorder treatments medication doses for older adults modified release stimulant preparations preferred in adults
Immediate release versus extended release
Impulsive behaviour, disinhibitory drug reactions, benzodiazepines
Inappropriate sexual behaviour in older people
Incongruence of affect, multiple sclerosis
Infant exposure
Inhaled administration acutely disturbed/violent patients antipsychotics
Initiation of risperidone ISM
Initiation schedules
Injectable diamorphine, prescribing guidelines for opioid dependency
Injections
In overdose
In-patient detoxification, alcohol withdrawal
In pregnancy Drug choice in pregnancy first-generation neurodevelopment effects second-generation
Insomnia in pregnancy melatonin use in children and adolescents menopausal women people living with human immunodeficiency virus
Integrase strand transfer inhibitors, psychiatric adverse reactions
Intentional non-adherence
Interactions between illicit drugs and psychotropics
Interactions with caffeine
interferons-a and Ã, psychiatric adverse effects
international normalised ratio (INR), psychotropic agent effects
Interpreting sample results for drugs with established target ranges
Interruptions in treatment
Interstitial lung disease
Interstitial nephritis
Interventions for non-adherence
intracranial/intracerebral haemorrhage, SSRI risks